Purinergic Signalling

Scope & Guideline

Charting New Territories in Purinergic Signaling

Introduction

Welcome to your portal for understanding Purinergic Signalling, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN1573-9538
PublisherSPRINGER
Support Open AccessNo
CountryNetherlands
TypeJournal
Convergefrom 2004 to 2024
AbbreviationPURINERG SIGNAL / Purinergic Signal.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressVAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS

Aims and Scopes

The journal 'Purinergic Signalling' focuses on the diverse roles of purines and purinergic receptors in various biological processes and diseases. It aims to advance understanding of purinergic signaling and its implications for therapeutic interventions.
  1. Purinergic Signaling Mechanisms:
    Exploration of the biochemical pathways and molecular mechanisms involving purines, including ATP and adenosine, in cellular communication and signaling.
  2. Role in Disease Pathology:
    Investigation into how purinergic signaling contributes to the pathophysiology of various diseases, including cancer, neurodegenerative diseases, cardiovascular conditions, and inflammation.
  3. Therapeutic Applications:
    Research on potential therapeutic approaches targeting purinergic receptors and signaling pathways for the treatment of diseases such as cancer, pain, and inflammatory disorders.
  4. Neuropharmacology:
    Studies on the effects of purines on the nervous system, including their roles in neuroprotection, synaptic transmission, and neuroinflammation.
  5. Cellular and Molecular Biology:
    Research focusing on the cellular mechanisms of purinergic signaling, including receptor expression, signal transduction, and interactions with other signaling pathways.
The journal is increasingly focusing on emerging themes and trends in purinergic signaling research, reflecting the evolving landscape of this field.
  1. Purinergic Signaling in Cancer:
    A growing body of research is investigating the roles of purinergic receptors, especially P2X and P2Y families, in tumor progression, metastasis, and the immune response in cancer.
  2. Neuroinflammation and Neurodegeneration:
    There is an emerging focus on the role of purinergic signaling in neuroinflammatory processes and neurodegenerative diseases, highlighting its potential as a therapeutic target.
  3. Electroacupuncture and Pain Management:
    Recent studies are increasingly exploring the role of purinergic signaling in the mechanisms of acupuncture analgesia, positioning it as a promising area for pain management research.
  4. Microglial Function and Purinergic Modulation:
    Research on microglial cells and their purinergic signaling pathways is trending, emphasizing their role in neuroinflammation and brain health.
  5. Machine Learning in Purinergic Research:
    The application of machine learning techniques to identify novel ligands and predict receptor interactions is an emerging trend, indicating a shift towards more computational approaches in purinergic research.

Declining or Waning

While the journal continues to publish a wide range of topics, certain themes have shown a decline in frequency or prominence over the recent years.
  1. Historical Perspectives on Purinergic Research:
    Papers focusing on historical reviews or tributes to foundational figures in purinergic research have decreased, suggesting a shift towards more contemporary applications and findings.
  2. Basic Science without Clinical Relevance:
    There is a noticeable reduction in publications that are strictly focused on basic science without clear clinical implications, as the journal appears to be prioritizing studies with direct therapeutic relevance.
  3. Purinergic Mechanisms in Non-Mammalian Models:
    Research on purinergic signaling in non-mammalian systems has become less frequent, indicating a possible shift towards mammalian models that are more relevant to human health and disease.

Similar Journals

FASEB JOURNAL

Pioneering Insights in Biochemistry, Genetics, and Medicine
Publisher: WILEYISSN: 0892-6638Frequency: 12 issues/year

FASEB JOURNAL, published by Wiley, stands as a leading interdisciplinary platform in the realm of biological sciences, prominently featured in the United States. With an impressive 2023 impact factor placing it in the Q1 category across various fields including Biochemistry, Biotechnology, Genetics, Molecular Biology, and Medicine (miscellaneous), the journal is recognized for its substantial contribution to advancing knowledge and innovation. It serves as a vital resource for researchers, professionals, and students alike, providing high-quality, peer-reviewed articles that explore the molecular and cellular mechanisms underlying health and disease. The FASEB JOURNAL not only emphasizes accessible scientific communication but also fosters collaboration within these dynamic fields, making it an essential publication for anyone engaged in cutting-edge life sciences research. To explore more about the journal's offerings and access its vast repository of scholarly articles, visit their official page.

NATURE REVIEWS MOLECULAR CELL BIOLOGY

Connecting research and application in the life sciences.
Publisher: NATURE PORTFOLIOISSN: 1471-0072Frequency: 12 issues/year

NATURE REVIEWS MOLECULAR CELL BIOLOGY, published by NATURE PORTFOLIO, stands as a seminal journal in the fields of cell and molecular biology, with a significant impact factor that underscores its influence and reputation within the scientific community. Established in 2000 and continuing its legacy into 2024, this journal delivers comprehensive reviews that synthesize current knowledge and advancements in molecular and cellular processes. Respected for its high-quality articles, it has maintained a prestigious Q1 ranking in both Cell Biology and Molecular Biology categories as of 2023. With an exceptional Scopus ranking, taking the top position in its category, it attracts a readership of prominent researchers, professionals, and students eager to stay abreast of groundbreaking discoveries and methodologies. Although it does not offer Open Access, subscribers benefit from exclusive access to vital insights that foster innovative research approaches and advancements in the life sciences. The journal’s objective is to bridge the gap between research and application, providing indispensable resources to its audience while contributing to the global conversation on molecular and cellular biology.

ACTA NEUROBIOLOGIAE EXPERIMENTALIS

Illuminating the Complexities of Medicine and Mind
Publisher: NENCKI INST EXPERIMENTAL BIOLOGYISSN: 0065-1400Frequency: 4 issues/year

ACTA NEUROBIOLOGIAE EXPERIMENTALIS, an esteemed journal published by the Nencki Institute of Experimental Biology in Poland, has been a pivotal platform for the dissemination of research in the fields of medicine and neuroscience since its inception in 1970. With an ISSN of 0065-1400 and an E-ISSN of 1689-0035, this journal has consistently aimed to contribute to the understanding of neurobiological phenomena, cementing its status within the academic community. Despite its current categorization in the Q3 and Q4 quartiles for Medicine and Neuroscience respectively, ACTA NEUROBIOLOGIAE EXPERIMENTALIS continues to uphold rigorous scientific standards, providing an invaluable resource for researchers, professionals, and students alike. As an essential scholarly outlet, it encourages the exploration of groundbreaking findings and clinical applications in neurobiology, making it an attractive choice for those eager to advance their understanding of this intricate field.

FOLIA BIOLOGICA

Nurturing Scholarly Dialogue in Molecular Biology
Publisher: CHARLES UNIV PRAGUE, FIRST FACULTY MEDICINEISSN: 0015-5500Frequency: 6 issues/year

FOLIA BIOLOGICA, published by Charles University Prague, First Faculty of Medicine, is an esteemed academic journal that has been contributing to the fields of Biochemistry, Cell Biology, Developmental Biology, Genetics, Immunology, and Molecular Biology since its inception in 1961. With an ISSN of 0015-5500, this journal serves as a vital platform for researchers and professionals to disseminate their findings and advance knowledge within these disciplines. Despite its current Category Quartiles ranking in the lower tiers (Q3 and Q4), FOLIA BIOLOGICA continues to provide valued insights and foster scholarly dialogue, particularly in its paralleled fields. The journal is headquartered in Prague, Czech Republic, and operates without Open Access options, which emphasizes its focus on curated, peer-reviewed content essential for academicians and students. By bridging theoretical and practical knowledge, FOLIA BIOLOGICA remains committed to enriching the scientific community and serving as a cornerstone for future research innovations.

CELLULAR AND MOLECULAR BIOLOGY

Innovating Understanding in Molecular Biology
Publisher: C M B ASSOCISSN: 0145-5680Frequency: 8 issues/year

Cellular and Molecular Biology is a prominent academic journal published by C M B ASSOC, specializing in the dynamic fields of cellular and molecular biology. Established in 1977, this journal has consistently aimed to disseminate groundbreaking research that contributes to our understanding of biochemical processes, cell dynamics, and molecular mechanisms governing life. With its ISSN 0145-5680 and E-ISSN 1165-158X, the journal plays a vital role in the exchange of innovative ideas, evidenced by its coverage of research from 1977 to 2024. Although currently categorized in the Q4 quartile for major disciplines such as Biochemistry and Cell Biology, it is dedicated to fostering the development of the field by welcoming submissions that challenge the conventional understanding and lead to novel insights. Researchers and academics looking to contribute to or stay updated in the rapidly evolving landscape of molecular biology will find this journal a valuable resource for connecting with a global community of scientists.

Cell and Bioscience

Exploring the Intersection of Science and Innovation
Publisher: BMCISSN: Frequency: 1 issue/year

Cell and Bioscience is a prestigious open-access journal published by BMC that has been at the forefront of biochemistry, genetics, and molecular biology since its inception in 2011. With an impressive impact factor, this journal has established itself as a vital resource for researchers and professionals in these rapidly advancing fields, reflecting its high ranking of #29 out of 221 in the Scopus classification and placing it in the 87th percentile. Based in the United Kingdom, Cell and Bioscience aims to foster innovation and dissemination of research findings addressing critical biological questions through rigorous peer-reviewed articles and inter-disciplinary approaches. The journal's open-access model ensures unrestricted access to transformative research, promoting collaboration and knowledge sharing among academics, students, and practitioners worldwide. With a commitment to maintaining excellence in the field, Cell and Bioscience provides an essential platform for those looking to contribute to the evolving landscape of biosciences.

FASEB BioAdvances

Exploring Breakthroughs in Biological Research
Publisher: WILEYISSN: Frequency: 12 issues/year

FASEB BioAdvances, published by WILEY, is an esteemed open-access journal dedicated to advancing the fields of biochemistry, molecular biology, and physiology. Since its inception in 2019, the journal has rapidly established a significant presence within the academic community, boasting an impressive impact factor reflective of its Q2 and Q3 standings across various categories, including Biochemistry, Genetics and Molecular Biology, Cancer Research, Molecular Medicine, and Physiology. The journal aims to disseminate high-quality research and innovative findings to enhance the understanding of biological processes, making it a vital resource for researchers, professionals, and students alike. With its commitment to open access, FASEB BioAdvances ensures that groundbreaking research is available to a global audience, facilitating collaboration and exploration in these rapidly evolving scientific domains.

ACTA HISTOCHEMICA

Connecting Scholars to Shape the Future of Histochemistry
Publisher: ELSEVIER GMBHISSN: 0065-1281Frequency: 8 issues/year

ACTA HISTOCHEMICA, a prestigious journal published by Elsevier GmbH, is dedicated to advancing the field of histochemistry and its applications within cell biology and medicine. With an ISSN of 0065-1281 and an E-ISSN of 1618-0372, the journal provides a critical platform for the dissemination of high-quality research findings and reviews, integral for both emerging and established scholars. Since its inception in 1954 and continuing through to 2024, ACTA HISTOCHEMICA has maintained a strong commitment to publishing significant advancements in histology and cell biology, as evidenced by its categorization in Q3 for Cell Biology and Histology, as well as Q2 in miscellaneous medicine for the year 2023. The journal ranks favorably in Scopus, holding the 27th rank in Histology and a 200th rank in Cell Biology, highlighting its importance to the academic community. With its headquarters in Munich, Germany, ACTA HISTOCHEMICA continues to attract contributions from global researchers, fostering an international dialogue essential for the growth of knowledge in histochemistry and related disciplines.

Genes & Diseases

Innovating solutions through genetic research and discovery.
Publisher: KEAI PUBLISHING LTDISSN: 2352-4820Frequency: 6 issues/year

Genes & Diseases, published by KEAI PUBLISHING LTD, is a premier open-access journal dedicated to advancing the fields of genetics, biochemistry, and molecular biology. Established in 2014 and headquartered in Beijing, China, this journal has quickly risen to prominence, securing a place in the prestigious Q1 quartile in Biochemistry and Genetics (clinical), as well as Q2 in Cell Biology and Q1 in Molecular Biology as of 2023. With a commitment to disseminating cutting-edge research, Genes & Diseases serves as a critical platform for researchers, professionals, and students alike, ensuring that high-quality scientific work is openly accessible to the global community. The journal's exceptional impact is underscored by its selective Scopus rankings, which reflect its influence and relevance in key scientific domains, making it an essential resource for those exploring the intersections of genetics and disease pathology.

INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Unlocking the Secrets of Life at the Cellular Level
Publisher: PERGAMON-ELSEVIER SCIENCE LTDISSN: 1357-2725Frequency: 12 issues/year

The International Journal of Biochemistry & Cell Biology, published by Pergamon-Elsevier Science Ltd, stands as a pivotal resource in the fields of biochemistry and cell biology. With an ISSN of 1357-2725 and an E-ISSN of 1878-5875, this prestigious journal has been a key platform for disseminating cutting-edge research since its inception in 1995. The journal currently holds an impressive Q1 ranking in Biochemistry and a Q2 ranking in Cell Biology for the year 2023, reflecting its commitment to high-quality research and its influence within the scientific community. With a significant Scopus ranking of 94/438 in Biochemistry and 96/285 in Cell Biology, the journal plays a crucial role in advancing knowledge and fostering innovative approaches in these dynamic fields. Though it is not an open-access journal, the International Journal of Biochemistry & Cell Biology remains accessible to a wide audience, making it a vital resource for researchers, professionals, and students alike, who are eager to explore and contribute to the ongoing advancements in biochemistry and cell biology.